Kalender

11. sept. 2026, kl. 9.00-11.00

Analyses of the Potential Protective Impact of Probiotics during Biological Challenges and Non-Surgical Periodontal Therapy in

PhD defence by Christine Marie Lundtorp Olsen

11. sept. 2026, kl. 11.00-14.00

Adipose tissue dysfunction in cancer - transcriptional, lipidomic and metabolic mechanisms

PhD defence by Anna Martha Hammershøi Madsen

11. sept. 2026, kl. 13.00

MD, PhD Morten Ruhwald’s Doctoral Defence

On Friday 11 September 2026 at 13:00 MD, PhD Morten Ruhwald will defend his doctoral dissertation to be awarded the doctoral degree in medical science (dr.med.) (DMSc.).

Dissertation

”Transforming Tuberculosis Diagnostics: Innovation and Global Impact”

11. sept. 2026, kl. 14.00-17.00

PhD defence by Lone Musaeus Poulsen

Functional status of intensive care unit patients - Pre-admission status and outcomes

14. sept. 2026, kl. 14.00-17.00

Diagnostic assessment of culturally diverse memory clinic patients - Clinical utility of blood biomarkers and cross-cultural co

PhD defence by Daniel Kjærgaard

15. sept. 2026, kl. 14.00-17.00

PhD defence by Jacob Worm

The Long-Term Impact of Trigeminal Neuralgia - Comorbidity and Treatment Outcomes

16. sept. 2026, kl. 13.00-16.00

Medication Information in Transition: Practices and experiences of information sharing between general practice and hospital ca

PhD defence by Stine Søndersted Clausen

16. sept. 2026, kl. 14.00-17.00

PhD defence by Mads Damsgaard Wewer

Mechanisms, Management and Malignancies in Inflammatory Bowel Disease - Fibroblast Characterisation and Prognosis in Population-Based Cohorts

17. sept. 2026, kl. 14.00-17.00

Aspects of penile cancer development - Exploring the role of penile lichen sclerosus and human papillomavirus in penile cancer

PhD defence by Marianne Gardar Stærk

18. sept. 2026, kl. 9.30-17.00

CO-HEP Symposium - 20-year Anniversary of Copenhagen Hepatitis C Program (CO-HEP)

We have the pleasure of inviting you to celebrate the 20-year Anniversary of Copenhagen Hepatitis C Program (CO-HEP) following the HCV-Flavi2026 Congress.